Upload
rakeshmoney99
View
216
Download
0
Embed Size (px)
Citation preview
7/25/2019 CAMSON Investor Presentation July 2015
1/28
Investor Presentation
March 2016
Camson Bio Technologies Limited(BSE: 538858)
7/25/2019 CAMSON Investor Presentation July 2015
2/28
Cautionary Statement
2
This presentation contains statements that contain forward looking statements including, but
without limitation, statements relating to the implementation of strategic initiatives, and other
statements relating to Camson Bio Technologies Limiteds (Camson Bio Technologies) future
business developments and economic performance.
While these forward looking statements indicate our assessment and future expectations concerning
the development of our business, a number of risks, uncertainties and other unknown factors couldcause actual developments and results to differ materially from our expectations. These factors
include, but are not limited to, general market, macro-economic, governmental and regulatory trends,
movements in currency exchange and interest rates, competitive pressures, technological
developments, changes in the financial conditions of third parties dealing with us, legislative
developments, and other key factors that could affect our business and financial performance.
Camson Bio Technologies undertakes no obligation to publicly revise any forward looking statementsto reflect future / likely events or circumstances.
7/25/2019 CAMSON Investor Presentation July 2015
3/28
Contents
3
Company Overview1 5 - 11
Industry Dynamics2 13 - 15
Strategy: Path-to-Value3 17 - 19
Business Operations4 21 - 24
Financial Performance5 26 - 27
7/25/2019 CAMSON Investor Presentation July 2015
4/28
Company Overview
4
7/25/2019 CAMSON Investor Presentation July 2015
5/28
Camson: At a Glance
5
Pioneer in zero residue biocide products, supported by scientific research spanning over two decades
Camson Bio Technologies Limited (Camson or the Company) is India's first integrated IPR driven
agricultural biotechnology company
Founded in 1993, Camson is headquartered in Bangalore, with primary focus on biotech R&D
Pioneer in zero residue farming products, which uses secondary metabolites (biological origin) of microbes
to kill / inhibit pathogens, with no use of chemicals
Recently filed patents for its discovery of Natural Fertilizer
Recognized by Deloitte as one the fastest growing technology companies in 2015 and conferred the
Technology Fast 500 award and awarded Leadersof Tomorrow Award by ET Now & Indiamart 2014-15
Long standing relationship with its institutional investors such as CLSA and SBI
4000+ microbes library
3Research Centers;(Bangalore, Aligarh and
Hyderabad)
R&D
2.7mnlitres perannum capacity
Production
22Bio pesticides
7Bio fertilizers
4Water Soluble
Natural Fertilizers
ProductType
7/25/2019 CAMSON Investor Presentation July 2015
6/28
Corporate History
6
1993-2000 2008 2010 2011 2012
1993: Startedoperations
1995: IPO and went
public
2000: Launched
Calphomil, Camsons
first product based on
microbial extract
Launched Zero
Residue line of farm
produce
Land procured forthe second
production unit at
Nangal, Himachal
Pradesh
Research begins
at Aligarh, UP
Among Forbes Asias
best 200 companies
under a billion
Technology Fast 50
India 2010 award from
Deloitte
Best Green SME
award from Yes Bank
Operationalized new
R&D centre at
Doballapur; investment of
Rs. 300 mn
CLSA committed an
investment of US$ 10 mn
Camson Agri Ventures
commenced operations
Signed MOUs with: 1) Kerala
Cardamom Processing and Marketing
Co., 2) Vazhakkulam PineappleGrowers, 3) Coconut Development
Board and 4) Zuari Agri Sciences Ltd.
First company globally to patent
Natural Fertilizers
Demerger of Seeds Business; Record
date of 22-Sep
Awarded
Leaders ofTomorrow
award by ET
Now &
Indiamart
Filed patent for
Natural
fertilizers
2013 20142015
Tie-up with HDFC Bank toadvance HDFCs BC
initiative
Organic certification by
USOCA, Dehradun
Capacity increase started
for the R&D unit in
Doballapur, Karnataka
Awarded top 100mid sized company
by Inc. India
Most innovative
award at SIAL, Abu
Dhabi
Indira Gandhi
Excellence Award
7/25/2019 CAMSON Investor Presentation July 2015
7/28
Geographical Presence and Distribution Network
Geographical Presence and Key Markets Sales & Distribution Network
Manufacturing Facilities
R&D Centres
Target Markets
Currently having pan-India
presence
Intends to enter in the International
markets
Target Farmers Category A: Export oriented
farmers
Category B: Farmers looking for a
remedial solution for a particular
pest/disease
Category C: Farmers who are
aware of environmental cons from
chemicals
Headquartered in Bangalore,
has a 50 acre R&D centre
and production facility in
Dodaballapur, Bangalore
Sales & Marketing
Officers
Authorized
Dealer
Retail
Farmers
Product
Development
Officers
Product
consultancy &
Demos
Marketing Mechanism:
Has clearing & forwarding agents across the country for
storage and handling
Also, employs Field Assistants at local level on a temporary basis
during sales promotions
7
7/25/2019 CAMSON Investor Presentation July 2015
8/28
Key Strengths and Core Competencies
8
R&D capabilities driving operational excellence and market positioning
First mover advantage in the
Zero Residue biocides market
Developed an in-house
proprietary technology platform
consisting of 4,000+ microbes
database, screening technology
and a natural compound library
Scientific results driven by state-
of-the art technology platform
Significant knowledge base of
microbes study
Recently filed patents for its
discovery of Natural Fertilizer
Technologically advanced
manufacturing process
Camson products uses secondary
metabolites with no live micro
organisms, thereby leading to
much higher shelf lives
Two company owned and two
contracted production facilities
Facilitate sales via two way
process: One of direct sales to the
retail shops and second is to
derive demand via product
demos and consultancy to the
farmers
Has a strong network of 2,600+
dealers, 300 distributors and
300+ marketing personnel spreadacross India
Highly Specialized
R&D CapabilitiesOperational Excellence
Well Established
Market Reach
7/25/2019 CAMSON Investor Presentation July 2015
9/28
Camson Differentiating Factors
9
Proprietary
Technology
Platform
(R&D)
Has competitive advantage in the Zero-residue bio inputs
With already established over 4,000 select microbial
library, has very low threat from new entrants
In-house R&D Units recognized by Ministry of Science and
Technology, Govt. of India
Production
Facilities
Have set up production facilities in North India as well as
South India, in order to cater to the diverse demand and
easy access to the markets
Biocides
USP
Camson biocides are target specific, bio degradable, high yielding and does not harm soil productivity
Longer shelf life and Pests/insects do not develop resistance to biocide even after multiple uses
Offer higher protection period
Zero-residue product
Entire Biocides research processtakes about 9 - 12 years
Future Scope: Wide Range of
Applications across the Industries
Recognition
Real-time market access
Waste Water Management
Waste Management
Life Sciences
Power Generation
7/25/2019 CAMSON Investor Presentation July 2015
10/28
Santosh Nair
WTD & Chief Executive Off icer
Having an experience of over 19 years in Banking
and Finance industry and previously worked with
organizations like Merrill Lynch and HDFC Bank
Prior to joining Camson, worked as Director, Global Wealth
Management, Merrill Lynch
At Camson, responsible for streamlining processes and
strengthening backend systems
Introduced several stringent performance benchmarks to boost the
quality of Camson products
Key Management and Board of Directors
10
Sound management team backed with years of experience and a mix of technical & financial skill set
Dhirendra Kumar
CMD & Chief Scientific Offi cer
Founded Camson Bio Technologies in 1993
A technocrat with passion for R&D, has led
Camsons pioneering research in Sciences like
Intragenics and Metagenomics
Spearheaded the development of zero-residue products, new
technological platforms and organically viable hybrid seeds. Previous experience includes ITC, Coromandal and Ranbaxy
At ITC, he took over a loss making division and reworked the entire
product range, positioning and strategy to transform it into the fastest
growing and most profitable division at ITC
Board of Directors
A.N. Singh Non-Executive Director
V.K. Singh Non-Executive Director
Krishnaswamy Ramaswamy Non-Executive, Independent Director
B.C. Madappa Non-Executive, Independent Director
Anurudh Kumar Singh Non-Executive, Independent Director
Reeta Gangwani Non-Executive, Independent Director
Gulshan K. Khanna Non-Executive, Independent Director
7/25/2019 CAMSON Investor Presentation July 2015
11/28
Recent Corporate Developments
11
Awards and Recognition
Camson recognized as one the fastest
growing technology companies in Asia
Pacific and received the Technology Fast500 award
Camson wins 2nd Inc India
Innovative 100 Award under
the category ResponsibleBusiness & Technology
Camson awarded ETNowLeadersof Tomorrow
Key Developments
Received approval from Shareholders and Creditors for the Scheme of Arrangement (Demerger) of the Seeds Business to create a
separate entity Camson Seeds Limited ; record date of 22-Sep-2015; On 14-Nov-2015, Board of Camson Seeds approved
allotment of shares to all who are the shareholders of Camson Biotech as on the record date; Allotment done in Jan 2016
Filed patents for the discovery of natural fertilizers
Appointed Deloitte Haskins & Sells as the statutory auditor of the Company
MOU with Zuari Agri Sciences to market Camson products through Zuarisdistribution network
MOU with the Kerala Cardamom Processing & Marketing Company to facilitate residue free farming for Kerala farmers
MOU with Vazhakkulam Pineapple Growers & Processors to advance the usage of biocide products in pineapple farming
MOU with the Coconut Development Board (a Government of India enterprise), to undertake research on secondary metabolite
based biocides to control red palm weevil infesting coconut plantations
7/25/2019 CAMSON Investor Presentation July 2015
12/28
Industry Dynamics
12
7/25/2019 CAMSON Investor Presentation July 2015
13/28
Industry Trends & Opportunities
13
Increasing
Food
Demand
World population projected to rise from 7.2 bn in 2014 to 9.6 bn in 2050E
Due to growing population, shifting diets and increasing purchasing power, the world will need to produce 69%more food calories in 2050 than 2006
Expected shortfall of food grains globally is 27.7 mmt by 2020 and 14.0 mmt in India by 2017
5.77.2
9.6
0.9 1.3 1.7
1994 2014 2050E
World Indian
Population Statistics (bn) Global Agricultural Total Factor
Productivity (TFP) Growth
1.75%
1.69%
Required growth
by 2050
Current rate of
growth
Agri
Ecological
Footprint
24%
Greenhouse Gas Emissions
(100% = 49 GT CO2) Agri sector itself contributes majorly
to environmental degradation mainly
on account of unhealthy agri practices
Long-term sustainability demands alarge scale shift to biocides based
healthy agriculture
Reducing
Arable
Land
Reducing arable land due to rapid industrialization
South Asia is currently using 94% of its potential arable land
Worldwide, over 0.5 mn tons of banned and unhealthy pesticides
are threatening the arable land
0.38 ha 0.23 ha 0.15 ha
1970 2000 2050
50%70%
Global Middle Class by 2050E
Current
Source: UN Population Report 2014, World Resource Institute Report on Global Food Challenges 2013, UN-FAO Agriculture Report
In Hectares (ha) / Person
37%
Earths Landmass Usage
(100% = 13.3 bn ha)
70%
Water Withdrawal
(100% = 3862 km3H2O)
Agri's Current Ecological Footprint
7/25/2019 CAMSON Investor Presentation July 2015
14/28
14%13%
17%
12%
22% 18%
Global Market Size
14
Crop Protection Industry (US$ bn) Organic Food Market (US$ bn)
Asia, Latin Americas and South Africa are projected to have highest
demand for organic foods in the future
71.2
104.5
161.5
2012 2015 2018
40
5571
2008 2013 2018
Increasing consumption and farmersneed for higher profitability are
driving the growth in crop protection industry
Biocides Market (US$ bn)
2012
7.3
47.2
2018
9.6
73.8
Biocides Market
Total Agri Input Market
Biocides
market to
grow at a
CAGR of
4.7% from
2012-2018
Region Wise Growth in Bio-Pesticide Markets
Significant export potential backed by robust growth in Biocides
market
Source: Lucient Report, Research & Markets Report 2014, BCC Research Report on Organic F&B 2014, Accenture Report 2013,
Transparency Market Report on Global Biocides Market 2015
7/25/2019 CAMSON Investor Presentation July 2015
15/28
37% 20% 6% 6% 5% 26%
Cotton Rice Chilli Wheat Vegetables Others
Pesticide Consumption Pattern in India
India Market Size
15
Crop Protection Industry (US$ bn) Key Industry Highlights
Approx. 2.5% of all agricultural land to be certified organic
by end 2015
Organic (fruits & dairy products) market to grow at a CAGR
of 13-14% and 10-11% respectively from 2012-2017
Total Indian Bio Input (including Genetically Modified)
market estimated to reach US$ 37.0 bn by 2025
Approx. 18% of the crop yield worth US$ 19.6 bn is lost dueto pests every year in India
Rising middle class and increased health awareness to influence the
demand for biocides in the Indian market
Bio-Pesticides Market (US$ bn)
3.8
6.8
2012 2017
0.16
0.35
2013 2018
Source: Tata Strategic Management Group, Care Report 2007, Dawn Magazine, SBI Cap, Technopak Organic Food Report 2012,
Camson Analysis
7/25/2019 CAMSON Investor Presentation July 2015
16/28
Strategy: Path-to-Value
16
7/25/2019 CAMSON Investor Presentation July 2015
17/28
Driving Long-term Growth
17
Focusing R&D efforts on developingcompelling technologies to continue
to deliver a sustainable pipeline of
new products
Pillars
of
Growth
Capitalizing on
our diverse
product range toaddress the
farmer needs for
zero-residue
products, thereby
creating
sustainable
demand and
revenue stream
Continuous focus on optimizing
operational costs and further
streamlining processes to achieve
excellence
Clearly Defined Strategic Plan
o Focus on the institutional desk business, both in
domestic and international markets
o Optimize utilization of existing manufacturing
platform to enhance capital efficiency andshareholder returns
o Continue to develop and patent the innovative
products
o
New Hybrids: Further stress upon productdevelopment
o Successful integration of recent corporate
MOUs which will bring scalability through a
larger research space and new customer base
7/25/2019 CAMSON Investor Presentation July 2015
18/28
Target Optimization Areas
18
Simplifying
Business Segments
Enhancing Market Reach
Improving Support
Functions
Develop best-in-class Agri Biotech (Biocides)
products
Demerger of Seeds business; In line with the core
strategy and optimization plan
To support the superior R&D capabilities, three target areas identified under the optimization plan
Deploy a mix of push and pull marketing strategy to
create demand and push sales
Deepen the product consultancy interaction with the
farmers
Focus on receivable timelines
Ensure sustained compliance with global regulatory
standards
o Improved
businessagility
o Liberating
resources to
re-invest in
R&D to fuel
further
growth
7/25/2019 CAMSON Investor Presentation July 2015
19/28
Demerger of the Seeds business
19
Demerger Highlights Rationale for Demerger
Camson Bio Technologies (CBTL)
(Pre Demerger)
Agri Biotech
(Biocides)
Segment
Seeds Segment
Seeds
Cultivation
Seeds Trading
Agri Biotech
(Biocides)
To operate only in the Agri
Biotech segment, backed by
advanced R&D capabilities
Camson Bio Technologies
(CBTL)
(Post Demerger)
Camson Seeds Ltd.
(New Entity)Seeds Segment
Spin off
Application filed with Karnataka High court, for the Demerger
of Seeds business to form a new entity (Camson Seeds Limited)1
Existing shareholders of CBTL allotted shares of Camson Seeds
ltd. in the ratio of 1:13
CBTL will continue to operate only the Agri biotech (Biocides)
business, focusing upon Zero-residue & eco friendly products4
Most dynamicslike risk, capital
requirements &
return ratios of
both businesses
begun to differ,
necessitating need
for the demerger
Enhance focus onthe rapidly growing
Agri-biotech
business, to further
scale it up
In line with the
Companys long-
term strategy
Changing Business
Dynamics
Cultivating Future
Growth
Enhancing
Market Position
Building brandequity
Further
penetrating the
Indian agri market
Shareholding pattern of Camson Seeds to be same as of CBTL2
7/25/2019 CAMSON Investor Presentation July 2015
20/28
Business Operations
20
7/25/2019 CAMSON Investor Presentation July 2015
21/28
R&D enabled Product Development
Multi-Stage Process
Identification
Metabolite Research
Testing and Production
Bio-medical facts are mined from scientific literature,
further to use in search for microbial sources
Microbe samples are sourced from various agro-climatic
zones
Camson uses in-house technology to facilitate the growthand multiplication of cultures
Extraction of primary and secondary metabolites, from
the cultures
Camsons manufacturing process is continuously
optimized to suit a huge spectrum of temperatures
Helps in mass production of biocides and reduce
operational costs
Field Trials
Camson uses multi-component formulations to develop
products whose ingredients have multiple effects
Has in-house capability over 300 acres of land, where
agro-climatic field trials are conducted
SubStages
Identifying target pathogen
Literature/data mining
Microbial source tracking
1
2
3
4
Isolation of microbes
Mass multiplication
Extraction of Sec Metabolites
Biocide testing
Production optimization
Product improvement
Formulations
Field trails
Process Description
A complex process developed over two decades of microbial research
21
7/25/2019 CAMSON Investor Presentation July 2015
22/28
Biocides Business
22
Ability to leverage its first mover advantage in a market with significant growth potential
Bio Insecticides Bio Fungicides Bio Fertilizers Bio Stimulants
Agri Biotech
Products
(Biocides)
Produced using secondary metabolites of microbes,
suitable for killing pests
Maximize agricultural productivity while reducing the
environmental impact
Products are highly specific in their action, non synthetic, economical and environmentally safe
Categorized into four product types: Bio Insecticides, Bio
Pesticides, Bio Fertilizers and Growth Stimulants
7/25/2019 CAMSON Investor Presentation July 2015
23/28
Product Range
23
Agri Biotech (Biocides)
Bio Insecticides
Help protect crops
and produce high
quality yield
Has unique mode ofaction, less toxic and
organic
Calgard
Cal-mb
Calhopp
Calmyte
Calterm
Calpaste
Calnova
Bio Fungicides
Help control fungi
and act as both:
Preventive and
Curative
Bio degradable
Bio Fertilizers
Maximize farm
potential by
promoting plant
growth
Improve productivity
Bio Stimulants
Make farm operations
more efficient by
plant growth
Reduce the cost of
cultivation
Calbahaar
Calmonas
Calderma
Caltop
Calbase
Calphomil
Calobium
Calphorus
Calosphere
Calspiral
Caltash
Calzoto
Calshri
Calstim
Caltika
Camistrong
Calhume
7/25/2019 CAMSON Investor Presentation July 2015
24/28
Water Soluble Natural Fertilizers: New Segment
24
Natural Fertilizers enables effective mobilisation of nutrients to the plant
Camson is the First in the World to develop WaterSoluble Natural Fertilizers
derived 100% from natural sources; recently filed patent
Natural Fertilizer technology certified by the ControlUnion,a major certifier of
organic agri produce and inputs globally
Camson is capable to manufacture this in commercial quantities to meet the
increasing demand
Performance MetricsNatural Fertilizers Product Advantages
Bio Available NPK: Easier for the plant to absorb the
nutrients1
Do not leach or evaporate as in case of synthetic
fertilizers2
Free from Sodium, Chloride and other harmful
chemicals3
Completely and uniformly water soluble, 100%
Organic4
Germination: Increase of 10%-20%
Plant Height: Increase of 10%-12%
Girth: Increase of 5%
Yield: Increase of 10%-15%
Soil Microbe Count: Increase of 20%
7/25/2019 CAMSON Investor Presentation July 2015
25/28
Financial Performance
25
7/25/2019 CAMSON Investor Presentation July 2015
26/28
Select Financials: Biocides Business
26
Profit & Loss Statement1
(Rs. million) 30.09.2015
Short Term Borrowings2 358.4
Long Term Borrowings 99.5
Total Debt 457.9
Less: Cash & Cash Equivalents (11.0)
Net Debt 446.8
Net Worth 1,413.9
Total Debt / Net Worth (x) 0.32x
Capital Employed 1,871.8
Note:
1. During the year, the Company has received order from the High Court for the demerger of the seeds business of the Company with an appointed
date of 1st April, 2014. Accordingly the above results have been presented for the Agri Biotech business. Consequently, the Company operates in
a single segment, i.e. Agri Biotech and the results relating to previous quarter/period/year are not comparable
2. Short term borrowings include: a) Current portion of long-term maturities and b) Interest accrued but not due on borrowings & security deposit
(Rs. million) Q3 FY2016 Q2 FY2016 Q1 FY2016
Operating Revenue 45.5 122.6 142.4
EBITDA(including other income)
(61.5) 28.9 39.1
EBITDA Margin nm 23.6% 27.4%
Depreciation &
Amortization23.9 27.0 27.7
EBIT(including other income)
(85.0) 1.9 11.4
EBIT Margin nm 1.5% 8.0%
Leverage Profile1
7/25/2019 CAMSON Investor Presentation July 2015
27/28
7/25/2019 CAMSON Investor Presentation July 2015
28/28
Camson Bio Technologies Limited
(CIN: L85110KA1993PLC014944)
C-7, 7th Floor, Corporate Block
Golden Enclave, Old Airport Road, Bangalore - 560 017
Phone: +91 80 4076 8900; Fax: +91 80 2520 2285
Email: [email protected]
Website: www.camsonbiotechnologies.com
Neethi
Camson Bio
Technologies
+91 80 4076 8906
Saket Somani
Churchgate Partners
+91 22 6169 5988
mailto:[email protected]://www.camsonbiotechnologies.com/mailto:[email protected]:[email protected]:[email protected]:[email protected]://www.camsonbiotechnologies.com/mailto:[email protected]